MedPath

Laser Ablation Study for trEatment of atRial Fibrillation (LASER)

Phase 4
Completed
Conditions
Atrial Fibrillation
Interventions
Device: Laser ablation
Device: RF ablation
Registration Number
NCT02504567
Lead Sponsor
Hospital Clinic of Barcelona
Brief Summary

This protocol aims at assessing the efficacy of performing catheter ablation for atrial fibrillation (AF) with laser catheters versus performing it with radiofrequency (RF) catheters. In order to study laser catheter ablation efficacy, MRI analysis of the lesions 3 months after the procedure will be performed in both groups. MRI analysis will detect ablation gaps in the lesions encircling pulmonary veins. The primary endpoint will compare the number of gaps in the laser catheter and the RF group. The secondary endpoint of the study is recurrence of AF after 12 months. The target population of the study is patients with paroxysmal or persistent AF undergoing AF ablation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Patients with clinical recurrent AF, refractary or intolerant to at least 1 antiarrhythmic drub who are scheduled to undergo ablation of pulmonary veins (PV)
  • Signed consent form.
Exclusion Criteria
  • Being under 18 years old
  • Any contraindication for ablation procedure
  • Impossibility to acquire DE-MRI because of contraindication (e.g. severely impaired renal function) or patient unwillingness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Laser ablationLaser ablationAblation with laser catheter
RF ablationRF ablationAblation with RF catheter
Primary Outcome Measures
NameTimeMethod
Presence of large gaps in the delayed enhancement MRI (DE-MRI)3 months

The presence of MRI ablation gaps around the pulmonary veins evaluated with MRI images of the patient acquired three months after the ablation procedure. A large gap is described as a GAP that is larger or equal than 20% of the vein perimeter.

Secondary Outcome Measures
NameTimeMethod
To determine the number of patients that present atrial fibrillation after the ablation procedure1 year

The number of patients that present a recurrence in their atrial fibrillation after the ablation procedure during the first year.

Trial Locations

Locations (1)

Hospital Clínic de Barcelona

🇪🇸

Barcelona, Catalunya, Spain

© Copyright 2025. All Rights Reserved by MedPath